Tvardi Therapeutics (TVRD) Restructuring Costs (2024 - 2026)
Tvardi Therapeutics (TVRD) posted Restructuring Costs of $1.2 million for Q1 2026, down 3.36% sequentially from $1.2 million in Q4 2025, and up 90.54% YoY from $634000.0 in Q1 2025.
Tvardi Therapeutics (TVRD) Restructuring Costs (2024 - 2026) Analysis & Trends
Tvardi Therapeutics has reported Restructuring Costs for 3 years, with the latest figure at $1.2 million in Q1 2026.
- Quarterly Restructuring Costs rose 90.54% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.8 million (up 107.21% YoY) and the FY2025 annual result came in at $5.2 million, up 120.57% from the prior year.
- Restructuring Costs fell to $1.2 million in Q1 2026 per TVRD's latest filing, from $1.2 million in the prior quarter.
- Over five years, Restructuring Costs peaked at $2.4 million in Q1 2024 and troughed at $164000.0 in Q2 2024.
- A 3-year average of $1.2 million and a median of $1.2 million in 2025 frame the typical range for Restructuring Costs.
- The widest YoY moves for Restructuring Costs: up 1134.76% in 2025, down 73.59% in 2025.
- Over 3 years, Restructuring Costs stood at $1.6 million in 2024, then fell by 22.6% to $1.2 million in 2025, then dropped by 3.36% to $1.2 million in 2026.
- According to Business Quant data, Restructuring Costs over the past three periods registered $1.2 million, $1.2 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.14 Bn | 132.29 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 87.02 Bn | 79.03 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.30 Bn | 60.12 Bn | 1.37 Bn |
| 4 | Moderna | 60.84 Bn | 55.70 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.49 Bn | 28.18 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.78 Bn | 10.38 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.14 Bn | 26.31 Bn | - |
| 10 | Tvardi Therapeutics | 17.59 Mn | 17.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.21 Mn |
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Mar 31, 2025 | 634,000.00 |
| Dec 31, 2024 | 1.62 Mn |
| Sep 30, 2024 | 389,000.00 |
| Jun 30, 2024 | 164,000.00 |
| Mar 31, 2024 | 2.40 Mn |